Graves Diseases – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Graves Diseases – Drugs In Development, 2024 report and make more profitable business decisions.
Graves’ disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Symptoms include anxiety, weight loss, change in menstrual cycles, erectile dysfunction, bulging eyes, and irregular heartbeat. Risk factors include family history, age, autoimmune disorders, smoking, and pregnancy. Treatment includes anti-thyroid medications, beta blockers, and surgery.
The Graves Diseases drugs in development market research report provide comprehensive information on the therapeutics under development for Graves Diseases, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Graves Diseases and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Graves Diseases | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 16 molecules, with 16 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Graves Diseases therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Graves Diseases pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Graves Diseases treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
advanceCor GmbHAV7 Ltd
Conduit Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
ellennbe GmbH
GSK plc
HanAll Biopharma Co Ltd
Immunovant Inc
Lan-yi Therapeutics Ltd
Omeros Corp
OSE Immunotherapeutics SA
Protheragen Inc
Septerna Inc
Tourmaline Sub Inc
Virtici LLC
Worg Pharmaceuticals Hangzhou Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Graves Diseases reports